8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Mar 17, 2026·SEC
Material company update
Feb 3, 2026·SEC
Cabot Corporation(CBT)Earnings, Financials & Key Ratios
CBT•NYSE
14.7× P/E·Price updated Jun 17, 2026
AboutCabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.Show more
- Revenue$3.71B-7.0%
- EBITDA$775M+1.3%
- Net Income$331M-12.9%
- EPS (Diluted)6.02-10.4%
- Gross Margin25.32%+5.3%
- EBITDA Margin20.87%+9.0%
- Operating Margin16.73%+8.8%
- Net Margin8.91%-6.3%
- ROE20.09%-20.8%
CBT Key Insights
Cabot Corporation (CBT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 27.3%
- ✓14 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy dividend yield of 2.0%
- ✓Share count reduced 2.7% through buybacks
- ✓Trading near 52-week high
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CBT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CBT Price & Volume
Cabot Corporation (CBT) stock price & volume — 10-year historical chart
Loading chart...
CBT Growth Metrics
Cabot Corporation (CBT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years2.6%
5 Years7.27%
3 Years-4.93%
TTM-8.52%
Profit CAGR
10 Years-
5 Years-
3 Years16.56%
TTM-34.18%
EPS CAGR
10 Years-
5 Years-
3 Years18.48%
TTM-31.05%
Return on Capital
10 Years14.28%
5 Years20.1%
3 Years20.98%
Last Year21.33%
CBT Recent Earnings
Cabot Corporation (CBT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$1.61+9.5%
$1.47
Rev
$904M+0.4%
$900M
Q1 2026
Feb 3, 2026Metric
Actual
Est
EPS
$1.53+9.3%
$1.40
Rev
$849M-4.3%
$887M
Q4 2025
Nov 3, 2025Metric
Actual
Est
EPS
$1.70+1.2%
$1.68
Rev
$899M-3.3%
$930M
Q3 2025
Aug 4, 2025Metric
Actual
Est
EPS
$1.90+4.4%
$1.82
Rev
$923M-5.6%
$978M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $1.61vs $1.47+9.5% | $904Mvs $900M+0.4% |
| Q1 2026 | Feb 3, 2026 | $1.53vs $1.40+9.3% | $849Mvs $887M-4.3% |
| Q4 2025 | Nov 3, 2025 | $1.70vs $1.68+1.2% | $899Mvs $930M-3.3% |
| Q3 2025 | Aug 4, 2025 | $1.90vs $1.82+4.4% | $923Mvs $978M-5.6% |
Based on last 12 quarters of dataView full earnings history →
CBT Peer Comparison
Cabot Corporation (CBT) competitors in Carbon and activated carbon materials — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 KRO | 799.62M | 6.95 | -7.24 | -1.47% | -7.12% | -17% | 0.77 | |
 IOSP | 2.05B | 83.11 | 17.80 | -3.65% | 6.38% | 8.64% | 0.07 | |
 HWKN | 3.3B | 158.34 | 40.50 | 11.21% | 7.52% | 15.96% | 0.49 | |
 TROX | 1.21B | 7.57 | -2.55 | -5.73% | -12.3% | -30.42% | 2.48 | |
 ASIX | 560.48M | 20.79 | 11.55 | 0.31% | 0.67% | 1.28% | 0.47 | |
 ECVT | 1.41B | 12.88 | -21.11 | 2.7% | -7.71% | -10.2% | 0.71 | |
 PPG | 26.22B | 117.14 | 16.93 | 0.19% | 9.83% | 31.06% | ||
 EMN | 8.25B | 72.12 | 17.59 | -6.71% | 4.62% | 6.69% | 0.84 |
Compare CBT vs Peers
Cabot Corporation (CBT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CBT Income Statement
Cabot Corporation (CBT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 2.72B | 3.24B | 3.34B | 2.61B | 3.41B | 4.32B | 3.93B | 3.99B | 3.71B | 3.58B |
Revenue Growth % | 12.69% | 19.32% | 2.93% | -21.67% | 30.41% | 26.75% | -9.03% | 1.6% | -7.04% | -8.52% |
Cost of Goods Sold | 2.06B | 2.46B | 2.65B | 2.11B | 2.61B | 3.44B | 3.09B | 3.03B | 2.77B | 2.69B |
COGS % of Revenue | 76% | 75.91% | 79.47% | 80.87% | 76.56% | 79.52% | 78.66% | 75.96% | 74.68% | - |
Gross Profit | 652M▲ 0% | 781M▲ 19.8% | 685M▼ 12.3% | 500M▼ 27.0% | 799M▲ 59.8% | 885M▲ 10.8% | 839M▼ 5.2% | 960M▲ 14.4% | 940M▼ 2.1% | 885M▲ 0% |
Gross Margin % | 24% | 24.09% | 20.53% | 19.13% | 23.44% | 20.48% | 21.34% | 24.04% | 25.32% | 24.76% |
Gross Profit Growth % | 12.8% | 19.79% | -12.29% | -27.01% | 59.8% | 10.76% | -5.2% | 14.42% | -2.08% | - |
Operating Expenses | 319M | 628M | 379M | 479M | 345M | 496M | 313M | 346M | 319M | 309M |
OpEx % of Revenue | 11.74% | 19.37% | 11.36% | 18.32% | 10.12% | 11.48% | 7.96% | 8.66% | 8.59% | - |
Selling, General & Admin | 260M | 305M | 290M | 292M | 289M | 258M | 253M | 283M | 260M | 266M |
SG&A % of Revenue | 9.57% | 9.41% | 8.69% | 11.17% | 8.48% | 5.97% | 6.44% | 7.09% | 7% | - |
Research & Development | 56M | 66M | 60M | 57M | 56M | 55M | 57M | 63M | 59M | 57M |
R&D % of Revenue | 2.06% | 2.04% | 1.8% | 2.18% | 1.64% | 1.27% | 1.45% | 1.58% | 1.59% | - |
Other Operating Expenses | 0 | 254M | 29M | 130M | 0 | 183M | 3M | 0 | 0 | -1000K |
Operating Income | 336M▲ 0% | 156M▼ 53.6% | 306M▲ 96.2% | 21M▼ 93.1% | 454M▲ 2061.9% | 389M▼ 14.3% | 526M▲ 35.2% | 614M▲ 16.7% | 621M▲ 1.1% | 562M▲ 0% |
Operating Margin % | 12.37% | 4.81% | 9.17% | 0.8% | 13.32% | 9% | 13.38% | 15.37% | 16.73% | 15.72% |
Operating Income Growth % | 34.4% | -53.57% | 96.15% | -93.14% | 2061.9% | -14.32% | 35.22% | 16.73% | 1.14% | - |
EBITDA | 491M | 305M | 454M | 179M | 614M | 535M | 670M | 765M | 775M | 731M |
EBITDA Margin % | 18.07% | 9.41% | 13.61% | 6.85% | 18.01% | 12.38% | 17.04% | 19.15% | 20.87% | 20.45% |
EBITDA Growth % | 19.46% | -37.88% | 48.85% | -60.57% | 243.02% | -12.87% | 25.23% | 14.18% | 1.31% | -7.12% |
D&A (Non-Cash Add-back) | 155M | 149M | 148M | 158M | 160M | 146M | 144M | 151M | 154M | 169M |
EBIT | 344M | 171M | 314M | 20M | 455M | 391M | 541M | 610M | 640M | 574M |
Net Interest Income | -44M | -44M | -50M | -45M | -41M | -45M | -59M | -49M | -49M | -29M |
Interest Income | 9M | 10M | 9M | 8M | 8M | 11M | 31M | 32M | 27M | 28M |
Interest Expense | 53M | 54M | 59M | 53M | 49M | 56M | 90M | 81M | 76M | 39M |
Other Income/Expense | -32M | -27M | -50M | -51M | -45M | -44M | -70M | -79M | -49M | -48M |
Pretax Income | 288M▲ 0% | 117M▼ 59.4% | 256M▲ 118.8% | -30M▼ 111.7% | 409M▲ 1463.3% | 345M▼ 15.6% | 456M▲ 32.2% | 535M▲ 17.3% | 572M▲ 6.9% | 514M▲ 0% |
Pretax Margin % | 10.6% | 3.61% | 7.67% | -1.15% | 12% | 7.98% | 11.6% | 13.4% | 15.41% | 14.38% |
Income Tax | 29M | 193M | 70M | 191M | 123M | 102M | -28M | 111M | 196M | 187M |
Effective Tax Rate % | 10.07% | 164.96% | 27.34% | -636.67% | 30.07% | 29.57% | -6.14% | 20.75% | 34.27% | 36.38% |
Net Income | 241M▲ 0% | -113M▼ 146.9% | 157M▲ 238.9% | -238M▼ 251.6% | 250M▲ 205.0% | 209M▼ 16.4% | 445M▲ 112.9% | 380M▼ 14.6% | 331M▼ 12.9% | 285M▲ 0% |
Net Margin % | 8.87% | -3.49% | 4.7% | -9.1% | 7.33% | 4.84% | 11.32% | 9.51% | 8.91% | 7.97% |
Net Income Growth % | 61.75% | -146.89% | 238.94% | -251.59% | 205.04% | -16.4% | 112.92% | -14.61% | -12.89% | -34.18% |
Net Income (Continuing) | 273M | -74M | 186M | -221M | 286M | 243M | 484M | 424M | 376M | 327M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 121M | 125M | 136M | 123M | 143M | 134M | 143M | 165M | 155M | 119M |
EPS (Diluted) | 3.81▲ 0% | -1.83▼ 148.0% | 2.67▲ 245.9% | -3.96▼ 248.3% | 4.34▲ 209.6% | 3.62▼ 16.6% | 7.73▲ 113.5% | 6.72▼ 13.1% | 6.02▼ 10.4% | 5.46▲ 0% |
EPS Growth % | 61.44% | -148.03% | 245.9% | -248.31% | 209.6% | -16.59% | 113.54% | -13.07% | -10.42% | -31.05% |
EPS (Basic) | 3.89 | -1.87 | 2.67 | -3.96 | 4.36 | 3.65 | 7.79 | 6.79 | 6.07 | - |
Diluted Shares Outstanding | 62.7M | 61.7M | 58.8M | 56.6M | 56.8M | 56.9M | 56.5M | 55.7M | 54.2M | 52.2M |
Basic Shares Outstanding | 61.88M | 60.37M | 58.7M | 56.53M | 56.73M | 56.25M | 55.24M | 54.3M | 53.7M | 52M |
Dividend Payout Ratio | 31.95% | - | 50.96% | - | 32% | 40.19% | 19.78% | 24.47% | 29% | - |
CBT Balance Sheet
Cabot Corporation (CBT) balance sheet — assets, liabilities & shareholders' equity
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.26B | 1.39B | 1.21B | 978M | 1.43B | 1.82B | 1.63B | 1.6B | 1.54B | 1.55B |
Cash & Short-Term Investments | 280M | 175M | 169M | 151M | 168M | 206M | 238M | 223M | 258M | 252M |
Cash Only | 280M | 175M | 169M | 151M | 168M | 206M | 238M | 223M | 258M | 252M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 527M | 637M | 530M | 418M | 645M | 836M | 695M | 733M | 671M | 657M |
Days Sales Outstanding | 70.8 | 71.72 | 57.97 | 58.37 | 69.06 | 70.62 | 64.53 | 66.99 | 65.96 | 67.21 |
Inventory | 396M | 511M | 466M | 359M | 523M | 664M | 585M | 552M | 504M | 522M |
Days Inventory Outstanding | 70 | 75.79 | 64.14 | 61.98 | 73.14 | 70.54 | 69.06 | 66.41 | 66.34 | 69.88 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 108M | 0 | 106M | 116M |
Total Non-Current Assets | 2.05B | 1.86B | 1.79B | 1.8B | 1.88B | 1.71B | 1.98B | 2.13B | 2.28B | 2.35B |
Property, Plant & Equipment | 1.3B | 1.3B | 1.35B | 1.31B | 1.38B | 1.27B | 1.41B | 1.53B | 1.71B | 1.75B |
Fixed Asset Turnover | 2.08x | 2.50x | 2.48x | 1.99x | 2.48x | 3.40x | 2.78x | 2.60x | 2.17x | 2.79x |
Goodwill | 154M | 93M | 90M | 134M | 140M | 129M | 134M | 133M | 134M | 136M |
Intangible Assets | 137M | 98M | 96M | 103M | 100M | 63M | 60M | 53M | 55M | 53M |
Long-Term Investments | 56M | 52M | 39M | 39M | 40M | 20M | 20M | 23M | 16M | 66M |
Other Non-Current Assets | 150M | 185M | 58M | 160M | 172M | 178M | 172M | 388M | 180M | 194M |
Total Assets | 3.31B▲ 0% | 3.24B▼ 2.1% | 3B▼ 7.4% | 2.78B▼ 7.4% | 3.31B▲ 18.9% | 3.52B▲ 6.6% | 3.6B▲ 2.2% | 3.74B▲ 3.7% | 3.81B▲ 2.1% | 3.9B▲ 0% |
Asset Turnover | 0.82x | 1.00x | 1.11x | 0.94x | 1.03x | 1.23x | 1.09x | 1.07x | 0.97x | 0.93x |
Asset Growth % | 4.88% | -2.05% | -7.4% | -7.42% | 18.88% | 6.62% | 2.24% | 3.66% | 2.11% | 15.44% |
Total Current Liabilities | 741M | 952M | 599M | 529M | 1.15B | 1.1B | 822M | 772M | 957M | 1.07B |
Accounts Payable | 339M | 446M | 390M | 316M | 480M | 533M | 438M | 495M | 459M | 598M |
Days Payables Outstanding | 59.92 | 66.15 | 53.68 | 54.56 | 67.13 | 56.62 | 51.7 | 59.55 | 60.42 | 75.58 |
Short-Term Debt | 263M | 284M | 40M | 21M | 445M | 354M | 182M | 67M | 274M | 436M |
Deferred Revenue (Current) | -97M | 29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 22M | 26M | 118M | 46M | 75M | 66M | 55M | 167M | 77M | 0 |
Current Ratio | 1.70x | 1.46x | 2.02x | 1.85x | 1.24x | 1.65x | 1.98x | 2.08x | 1.61x | 1.45x |
Quick Ratio | 1.17x | 0.92x | 1.24x | 1.17x | 0.79x | 1.05x | 1.27x | 1.36x | 1.08x | 0.96x |
Cash Conversion Cycle | 80.87 | 81.36 | 68.43 | 65.79 | 75.07 | 84.53 | 81.88 | 73.84 | 71.88 | 61.51 |
Total Non-Current Liabilities | 970M | 1.01B | 1.27B | 1.44B | 1.07B | 1.39B | 1.38B | 1.37B | 1.15B | 1.14B |
Long-Term Debt | 661M | 719M | 1.02B | 1.09B | 717M | 1.09B | 1.09B | 1.15B | 856M | 863M |
Capital Lease Obligations | 0 | 10M | 9M | 89M | 84M | 83M | 84M | 111M | 85M | 85M |
Deferred Tax Liabilities | 38M | 42M | 41M | 58M | 73M | 65M | 50M | 42M | 39M | 162M |
Other Non-Current Liabilities | 253M | 284M | 238M | 197M | 195M | 151M | 147M | 69M | 173M | 239M |
Total Liabilities | 1.71B | 1.97B | 1.87B | 1.97B | 2.22B | 2.49B | 2.2B | 2.15B | 2.11B | 2.21B |
Total Debt | 924M | 1B | 1.06B | 1.2B | 1.25B | 1.53B | 1.36B | 1.33B | 1.22B | 1.3B |
Net Debt | 644M | 828M | 895M | 1.05B | 1.08B | 1.32B | 1.12B | 1.11B | 957M | 1.05B |
Debt / Equity | 0.58x | 0.78x | 0.94x | 1.48x | 1.14x | 1.48x | 0.97x | 0.84x | 0.71x | 0.77x |
Debt / EBITDA | 1.88x | 3.29x | 2.34x | 6.73x | 2.03x | 2.85x | 2.03x | 1.74x | 1.57x | 1.78x |
Net Debt / EBITDA | 1.31x | 2.71x | 1.97x | 5.88x | 1.76x | 2.47x | 1.67x | 1.45x | 1.23x | 1.43x |
Interest Coverage | 6.49x | 3.17x | 5.32x | 0.38x | 9.29x | 6.98x | 6.01x | 7.53x | 8.42x | 14.72x |
Total Equity | 1.6B▲ 0% | 1.28B▼ 20.1% | 1.13B▼ 11.3% | 814M▼ 28.2% | 1.09B▲ 33.9% | 1.03B▼ 5.3% | 1.41B▲ 36.3% | 1.59B▲ 13.0% | 1.71B▲ 7.2% | 1.69B▲ 0% |
Equity Growth % | 16.69% | -20.11% | -11.34% | -28.22% | 33.91% | -5.32% | 36.34% | 13.01% | 7.23% | 39.96% |
Book Value per Share | 25.53 | 20.73 | 19.29 | 14.38 | 19.19 | 18.14 | 24.90 | 28.55 | 31.46 | 32.32 |
Total Shareholders' Equity | 1.48B | 1.15B | 998M | 691M | 947M | 898M | 1.26B | 1.43B | 1.55B | 1.57B |
Common Stock | 62M | 61M | 57M | 57M | 57M | 56M | 55M | 54M | 53M | 52M |
Retained Earnings | 1.68B | 1.42B | 1.34B | 989M | 1.16B | 1.28B | 1.57B | 1.73B | 1.83B | 1.83B |
Treasury Stock | -6M | -7M | -5M | -4M | -4M | -4M | -3M | -3M | -3M | -3M |
Accumulated OCI | -259M | -317M | -391M | -351M | -289M | -439M | -362M | -360M | -335M | -316M |
Minority Interest | 121M | 125M | 136M | 123M | 143M | 134M | 143M | 165M | 155M | 119M |
CBT Cash Flow Statement
Cabot Corporation (CBT) cash flow — operating, investing & free cash flow history
| Metric | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 340M | 299M | 361M | 377M | 257M | 100M | 595M | 692M | 665M | 671M |
Operating CF Margin % | 12.51% | 9.22% | 10.82% | 14.42% | 7.54% | 2.31% | 15.14% | 17.33% | 17.91% | - |
Operating CF Growth % | -11.92% | -12.06% | 20.74% | 4.43% | -31.83% | -61.09% | 495% | 16.3% | -3.9% | 34.74% |
Net Income | 266M | -74M | 186M | -221M | 286M | 243M | 484M | 424M | 376M | 285M |
Depreciation & Amortization | 155M | 149M | 148M | 158M | 160M | 146M | 144M | 151M | 154M | 169M |
Stock-Based Compensation | 16M | 22M | 11M | 9M | 21M | 23M | 20M | 25M | 24M | 7M |
Deferred Taxes | -35M | 91M | -27M | 130M | 9M | -40M | -156M | -37M | 32M | -14M |
Other Non-Cash Items | -11M | 240M | 25M | 139M | 25M | 176M | 3M | 59M | 30M | 76M |
Working Capital Changes | -51M | -129M | 18M | 162M | -244M | -448M | 100M | 70M | 49M | 129M |
Change in Receivables | -23M | -110M | 73M | -59M | 7M | -287M | 153M | -26M | 76M | 106M |
Change in Inventory | -50M | -105M | 27M | 114M | -174M | -259M | 96M | 41M | 47M | 57M |
Change in Payables | 91M | 122M | -75M | -55M | 167M | 115M | -152M | 42M | -67M | -42M |
Cash from Investing | -149M | -246M | -94M | -288M | -186M | -118M | -214M | -235M | -298M | -302M |
Capital Expenditures | -147M | -229M | -224M | -200M | -195M | -211M | -244M | -241M | -274M | -212M |
CapEx % of Revenue | 5.41% | 7.06% | 6.71% | 7.65% | 5.72% | 4.88% | 6.21% | 6.03% | 7.38% | 5.93% |
Acquisitions | 0 | -64M | 132M | -92M | -92M | 70M | 6M | 0 | 0 | -93M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -2M | 47M | -2M | 4M | 101M | 23M | 24M | 6M | -24M | 3M |
Cash from Financing | -125M | -141M | -234M | -132M | -60M | 145M | -403M | -415M | -336M | -368M |
Debt Issued (Net) | -2M | -165M | 61M | 15M | 36M | 298M | -179M | -143M | -23M | -16M |
Equity Issued (Net) | -40M | -142M | -194M | -44M | 3M | -47M | -94M | -152M | -160M | -125M |
Dividends Paid | -77M | -80M | -80M | -80M | -80M | -84M | -88M | -93M | -96M | -97M |
Share Repurchases | -61M | -142M | -173M | -44M | -3M | -53M | -98M | -172M | -168M | -180M |
Other Financing | -14M | 246M | -23M | -23M | -19M | -22M | -42M | -27M | -57M | -130M |
Net Change in Cash | 80M▲ 0% | -105M▼ 231.3% | -6M▲ 94.3% | -18M▼ 200.0% | 19M▲ 205.6% | 36M▲ 89.5% | 32M▼ 11.1% | -15M▼ 146.9% | 35M▲ 333.3% | 39M▲ 0% |
Free Cash Flow | 193M▲ 0% | 70M▼ 63.7% | 137M▲ 95.7% | 177M▲ 29.2% | 62M▼ 65.0% | -111M▼ 279.0% | 351M▲ 416.2% | 451M▲ 28.5% | 391M▼ 13.3% | 459M▲ 0% |
FCF Margin % | 7.1% | 2.16% | 4.11% | 6.77% | 1.82% | -2.57% | 8.93% | 11.29% | 10.53% | 12.84% |
FCF Growth % | -29.56% | -63.73% | 95.71% | 29.2% | -64.97% | -279.03% | 416.22% | 28.49% | -13.3% | 59.38% |
FCF per Share | 3.08 | 1.13 | 2.33 | 3.13 | 1.09 | -1.95 | 6.21 | 8.10 | 7.21 | 8.79 |
FCF Conversion (FCF/Net Income) | 1.41x | -2.65x | 2.30x | -1.58x | 1.03x | 0.48x | 1.34x | 1.82x | 2.01x | 1.61x |
Interest Paid | 48M | 47M | 47M | 48M | 41M | 46M | 85M | 82M | 79M | 0 |
Taxes Paid | 69M | 84M | 99M | 71M | 93M | 129M | 140M | 136M | 165M | 0 |
CBT Key Ratios
Cabot Corporation (CBT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 16.21% | -7.85% | 13.01% | -24.44% | 26.26% | 19.7% | 36.49% | 25.36% | 20.09% | 16.75% |
Return on Invested Capital (ROIC) | 11.6% | 5.38% | 11.1% | 0.81% | 16.88% | 12.91% | 16.16% | 17.62% | 17.38% | 15.79% |
Gross Margin | 24% | 24.09% | 20.53% | 19.13% | 23.44% | 20.48% | 21.34% | 24.04% | 25.32% | 24.76% |
Net Margin | 8.87% | -3.49% | 4.7% | -9.1% | 7.33% | 4.84% | 11.32% | 9.51% | 8.91% | 7.97% |
Debt / Equity | 0.58x | 0.78x | 0.94x | 1.48x | 1.14x | 1.48x | 0.97x | 0.84x | 0.71x | 0.77x |
Interest Coverage | 6.49x | 3.17x | 5.32x | 0.38x | 9.29x | 6.98x | 6.01x | 7.53x | 8.42x | 14.72x |
FCF Conversion | 1.41x | -2.65x | 2.30x | -1.58x | 1.03x | 0.48x | 1.34x | 1.82x | 2.01x | 1.61x |
Revenue Growth | 12.69% | 19.32% | 2.93% | -21.67% | 30.41% | 26.75% | -9.03% | 1.6% | -7.04% | -8.52% |
Related:CBT Dividend History·CBT Revenue History·CBT Price History·CBT P/E History·CBT Financial Ratios·CBT Institutional Holders
CBT SEC Filings & Documents
Cabot Corporation (CBT) SEC filings — annual & quarterly reports (10-K, 10-Q)
CBT Frequently Asked Questions
Cabot Corporation (CBT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Cabot Corporation (CBT) reported $3.58B in revenue for fiscal year 2025. This represents a 93% increase from $1.86B in 1996.
Cabot Corporation (CBT) saw revenue decline by 7.0% over the past year.
Yes, Cabot Corporation (CBT) is profitable, generating $285.0M in net income for fiscal year 2025 (8.9% net margin).
Dividend & Returns
Yes, Cabot Corporation (CBT) pays a dividend with a yield of 2.00%. This makes it attractive for income-focused investors.
Cabot Corporation (CBT) has a return on equity (ROE) of 20.1%. This is excellent, indicating efficient use of shareholder capital.
Cabot Corporation (CBT) generated $459.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.